Preclinical research investigating the causes and potential treatments of ALS primarily relies on rat and mouse models, which overexpress mutated human SOD1 genes and exhibit similar patterns of pathology and disease progression to those observed in humans (100). This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.